• bitcoinBitcoin(BTC)$77,176.000.27%
  • ethereumEthereum(ETH)$2,523.88-0.48%
  • tetherTether(USDT)$1.000.00%
  • binancecoinBNB(BNB)$730.591.18%
  • rippleXRP(XRP)$1.371.03%
  • usd-coinUSDC(USDC)$1.000.00%
  • solanaSolana(SOL)$101.881.23%
  • tronTRON(TRX)$0.3400371.11%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.01-2.27%
  • zcashZcash(ZEC)$1,136.46-2.20%
  • HyperliquidHyperliquid(HYPE)$80.490.08%
  • dogecoinDogecoin(DOGE)$0.0849221.25%
  • RainRain(RAIN)$0.015300-2.51%
  • moneroMonero(XMR)$533.534.17%
  • USDSUSDS(USDS)$1.00-0.01%
  • whitebitWhiteBIT Coin(WBT)$80.240.11%
  • chainlinkChainlink(LINK)$11.52-0.77%
  • leo-tokenLEO Token(LEO)$9.11-0.48%
  • cardanoCardano(ADA)$0.2079251.77%
  • stellarStellar(XLM)$0.1809811.76%
  • Ethena USDeEthena USDe(USDE)$1.000.00%
  • daiDai(DAI)$1.000.02%
  • bitcoin-cashBitcoin Cash(BCH)$227.42-0.19%
  • USD1USD1(USD1)$1.000.00%
  • litecoinLitecoin(LTC)$53.851.00%
  • uniswapUniswap(UNI)$6.314.65%
  • CantonCanton(CC)$0.0974900.16%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.382.37%
  • Global DollarGlobal Dollar(USDG)$1.000.00%
  • hedera-hashgraphHedera(HBAR)$0.0746220.79%
  • avalanche-2Avalanche(AVAX)$7.39-1.09%
  • shiba-inuShiba Inu(SHIB)$0.0000052.51%
  • nearNEAR Protocol(NEAR)$2.37-6.90%
  • suiSui(SUI)$0.720.25%
  • crypto-com-chainCronos(CRO)$0.0585133.65%
  • paypal-usdPayPal USD(PYUSD)$1.00-0.02%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • MemeCoreMemeCore(M)$1.181.15%
  • tether-goldTether Gold(XAUT)$4,349.75-0.17%
  • Circle USYCCircle USYC(USYC)$1.140.00%
  • Ripple USDRipple USD(RLUSD)$1.000.01%
  • okbOKB(OKB)$113.290.19%
  • BittensorBittensor(TAO)$233.66-0.12%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.15-0.01%
  • aaveAave(AAVE)$126.261.81%
  • mantleMantle(MNT)$0.57-3.69%
  • pax-goldPAX Gold(PAXG)$4,355.59-0.13%
  • AsterAster(ASTER)$0.690.77%
  • World Liberty FinancialWorld Liberty Financial(WLFI)$0.0567367.21%
  • polkadotPolkadot(DOT)$1.03-1.37%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Meet DrugAssist: An Interactive Molecule Optimization Model that can Interact with Humans in Real-Time Using Natural Language

February 2, 2024
in AI & Technology
Reading Time: 5 mins read
A A
Meet DrugAssist: An Interactive Molecule Optimization Model that can Interact with Humans in Real-Time Using Natural Language
ShareShareShareShareShare

With the rise of Large Language Models (LLMs) in recent years, generative AI has made significant strides in the field of language processing, showcasing impressive abilities in a wide array of tasks. Given their potential in solving complex tasks, researchers have made quite a number of attempts to apply these models in the field of drug discovery to optimize the task. However, molecule optimization is one critical aspect of drug discovery that the LLMs have failed to affect significantly.

The existing methods generally focus on the patterns in the chemical structure provided by the data instead of leveraging the expert’s feedback and experience. This poses a problem as the drug discovery pipeline involves incorporating feedback from domain experts to refine the process further. In this work, the authors have tried to address the gaps in previous works by focusing on human-machine interaction and leveraging the interactivity and generalizability of powerful LLMs.

Researchers from Tencent AI Lab and Department of Computer Science, Hunan University released MolOpt-Instructions, which is a large instruction-based dataset for fine-tuning LLMs on molecule optimization tasks. This dataset has an adequate amount of data covering tasks associated with molecule optimization and ensures similarity constraints and a substantial difference in properties between molecules. Additionally, they have also proposed DrugAssist, a Llama-2-7B-Chat-based molecule optimization model capable of performing optimization interactively through human-machine dialogue. Through the dialogues, experts can further guide the model and optimize the initially generated results.

For evaluation, the researchers compared DrugAssist with two previous molecule optimization models and with three LLMs on metrics like solubility and BP and success rate and validity, respectively. As per the results, DrugAssist constantly achieved promising results in multi-property optimization and maintained optimized molecular property values within a given range.

Furthermore, the researchers demonstrated the exceptional capabilities of DrugAssist through a case study as well. Under the zero-shot setting, the model was asked to increase the values of two properties, BP and QED, by at least 0.1 simultaneously, and the model was successfully able to achieve the task even when it was exposed to the data during training only. 

Additionally, DrugAssist also successfully increased the logP value of a given molecule by 0.1, even though this property was not included in the training data. This showcases the good transferability of the model under zero-shot and few-shot settings, giving the users an option to combine individual properties and optimize them simultaneously. Lastly, in one of the interactions, the model generated a wrong answer by providing a molecule that did not meet the requirements. However, it corrected its mistake and provided a correct response based on human feedback.

In conclusion, DrugAssist is a molecule optimization model based on the Llama-2-7B-Chat model and is capable of interacting with humans in real time. It demonstrated exceptional results in single as well as multi-property optimizations and showed great transferability and iterative optimization capabilities. Lastly, the authors have aimed to improve the capabilities of the model further through multimodal data handling, which will significantly enhance and optimize the process of drug discovery.


Check out the Paper and Github. All credit for this research goes to the researchers of this project. Also, don’t forget to follow us on Twitter and Google News. Join our 36k+ ML SubReddit, 41k+ Facebook Community, Discord Channel, and LinkedIn Group.

If you like our work, you will love our newsletter..

Don’t Forget to join our Telegram Channel


YOU MAY ALSO LIKE

Altman Says OpenAI Will Match Anthropic’s Embedded Evaluator Pledge – Unite.AI

Anthropic’s CEO Proposes A Three-Step Plan To Curb AI Development

Asif Razzaq is the CEO of Marktechpost Media Inc.. As a visionary entrepreneur and engineer, Asif is committed to harnessing the potential of Artificial Intelligence for social good. His most recent endeavor is the launch of an Artificial Intelligence Media Platform, Marktechpost, which stands out for its in-depth coverage of machine learning and deep learning news that is both technically sound and easily understandable by a wide audience. The platform boasts of over 2 million monthly views, illustrating its popularity among audiences.


🎯 [FREE AI WEBINAR] ‘Using ANN for Vector Search at Speed & Scale (Demo on AWS)’ (Feb 5, 2024)


Credit: Source link

ShareTweetSendSharePin

Related Posts

Altman Says OpenAI Will Match Anthropic’s Embedded Evaluator Pledge – Unite.AI
AI & Technology

Altman Says OpenAI Will Match Anthropic’s Embedded Evaluator Pledge – Unite.AI

September 12, 2026
Anthropic’s CEO Proposes A Three-Step Plan To Curb AI Development
AI & Technology

Anthropic’s CEO Proposes A Three-Step Plan To Curb AI Development

September 12, 2026
Amodei Calls for Slowing the Pace of AI Capability Improvement – Unite.AI
AI & Technology

Amodei Calls for Slowing the Pace of AI Capability Improvement – Unite.AI

September 12, 2026
Are You Using The Right Ethernet Port On Your Router? Here’s How To Know
AI & Technology

Are You Using The Right Ethernet Port On Your Router? Here’s How To Know

September 12, 2026
Next Post
Migrants continue to face horrific conditions by smugglers in Mexico

Migrants continue to face horrific conditions by smugglers in Mexico

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Destroy My Finances and Move to the Bahamas?

Destroy My Finances and Move to the Bahamas?

September 6, 2026
GPT-6 Astra is a Monster… That Still Needs You!

GPT-6 Astra is a Monster… That Still Needs You!

September 8, 2026
Carclo plc (CCEGF) Shareholder/Analyst Call Transcript

Carclo plc (CCEGF) Shareholder/Analyst Call Transcript

September 9, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!